chr9-122568473-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004454.2(OR1L8):āc.5A>Gā(p.Glu2Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000447 in 1,565,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004454.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR1L8 | NM_001004454.2 | c.5A>G | p.Glu2Gly | missense_variant | 5/5 | ENST00000641027.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR1L8 | ENST00000641027.1 | c.5A>G | p.Glu2Gly | missense_variant | 5/5 | NM_001004454.2 | P1 | ||
ENST00000431442.2 | n.1363-38173T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000231 AC: 5AN: 216290Hom.: 0 AF XY: 0.0000344 AC XY: 4AN XY: 116392
GnomAD4 exome AF: 0.00000283 AC: 4AN: 1413434Hom.: 0 Cov.: 28 AF XY: 0.00000143 AC XY: 1AN XY: 700580
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152294Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.5A>G (p.E2G) alteration is located in exon 1 (coding exon 1) of the OR1L8 gene. This alteration results from a A to G substitution at nucleotide position 5, causing the glutamic acid (E) at amino acid position 2 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at